182 related articles for article (PubMed ID: 31835505)
1. Weight Gain and
Lattanzi B; D'Ambrosio D; Tavano D; Pitoni D; Mennini G; Ginanni Corradini S; Rossi M; Merli M
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31835505
[TBL] [Abstract][Full Text] [Related]
2. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
[TBL] [Abstract][Full Text] [Related]
3. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
[TBL] [Abstract][Full Text] [Related]
5. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
[TBL] [Abstract][Full Text] [Related]
6. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic steatohepatitis in posttransplantation liver: Review article.
Andrade ARCF; Cotrim HP; Bittencourt PL; Almeida CG; Sorte NCAB
Rev Assoc Med Bras (1992); 2018 Feb; 64(2):187-194. PubMed ID: 29641680
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity.
van den Berg EH; Douwes RM; de Meijer VE; Schreuder TCMA; Blokzijl H
Dig Liver Dis; 2018 Jan; 50(1):68-75. PubMed ID: 28935188
[TBL] [Abstract][Full Text] [Related]
9. New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation.
Andrade AR; Bittencourt PL; Codes L; Evangelista MA; Castro AO; Sorte NB; Almeida CG; Bastos JA; Cotrim HP
Ann Hepatol; 2017 November-December,; 16(6):932-940. PubMed ID: 29055928
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation.
Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G
Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770
[TBL] [Abstract][Full Text] [Related]
11. Outcome of liver transplantation in patients with prior bariatric surgery.
Safwan M; Collins KM; Abouljoud MS; Salgia R
Liver Transpl; 2017 Nov; 23(11):1415-1421. PubMed ID: 28752920
[TBL] [Abstract][Full Text] [Related]
12. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation.
Narayanan P; Mara K; Izzy M; Dierkhising R; Heimbach J; Allen AM; Watt KD
Transplantation; 2019 Jan; 103(1):e14-e21. PubMed ID: 29994981
[TBL] [Abstract][Full Text] [Related]
13. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.
Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J
Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607
[TBL] [Abstract][Full Text] [Related]
14. De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation.
Kappus M; Abdelmalek M
Clin Liver Dis; 2017 May; 21(2):321-335. PubMed ID: 28364816
[TBL] [Abstract][Full Text] [Related]
15. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
[TBL] [Abstract][Full Text] [Related]
16. Weight gain after orthotopic liver transplantation: is nonalcoholic fatty liver disease cirrhosis a risk factor for greater weight gain?
Kouz J; Vincent C; Leong A; Dorais M; Räkel A
Liver Transpl; 2014 Oct; 20(10):1266-74. PubMed ID: 25044355
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Recurrent NASH-Related Allograft Cirrhosis.
Kakar S; Dugum M; Cabello R; Humar A; Ahmad J; Malik SM
Dig Dis Sci; 2019 May; 64(5):1356-1363. PubMed ID: 30560336
[TBL] [Abstract][Full Text] [Related]
18. Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases.
Kennedy C; Redden D; Gray S; Eckhoff D; Massoud O; McGuire B; Alkurdi B; Bloomer J; DuBay DA
HPB (Oxford); 2012 Sep; 14(9):625-34. PubMed ID: 22882200
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States.
Doycheva I; Issa D; Watt KD; Lopez R; Rifai G; Alkhouri N
J Clin Gastroenterol; 2018 Apr; 52(4):339-346. PubMed ID: 28961576
[TBL] [Abstract][Full Text] [Related]
20. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
